UCL cancer institute data access commitee

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001008800	We copy number profiled 688 tumor regions from 300 patients presenting with advanced prostate cancer and prospectively followed-up (median, 7 years) in the control group of the STAMPEDE trial. Patients were categorised into four metastatic states, namely high-risk non-metastatic (with or without local lymph node involvement) or metastatic (low or high volume).	Illumina NovaSeq 6000	603